Robertson L W, Parkinson A, Campbell M A, Safe S
Chem Biol Interact. 1982 Oct;42(1):53-66. doi: 10.1016/0009-2797(82)90141-7.
The synthesis of all possible laterally-substituted polybrominated biphenyl (PBB) congeners containing two para bromines is described. Using enzymic, electrophoretic and ligand-binding assays that distinguish between phenobarbitone(PB)- and 3-methylcholanthrene(MC)-type inducers, the synthetic PBBs were evaluated as inducers of liver microsomal drug-metabolizing enzymes in the immature male Wistar rat. 4,4'-Dibromobiphenyl resembled PB in its mode of induction whereas all the meta-brominated derivatives of 4,4'-dibromobiphenyl, namely 3,4,4'-tri, 3,4,4',5-tetra-, 3,3', 4,4'-tetra-, 3,3',4,4',5-penta- and 3,3',4,4',5,5'-hexabromobiphenyl, resembled MC in their mode of induction. The results obtained with 3,4,4'-tribromobiphenyl demonstrate that, in contrast to the polychlorinated biphenyls (PCBs), a single meta halogen substituent is sufficient to abolish the PB-type characteristics of 4,4'-dibromobiphenyl and convert it to a strictly MC-type inducer. PBBs which induce AHH activity must be substituted at both para positions and at one, two, three or four meta positions. Ortho-substitution of PBBs which contain only lateral bromine groups may also give compounds which are aryl hydrocarbon hydroxylase (AHH) inducers. One of the MC-type PBBs, namely 3,3',4,4'-tetrabromobiphenyl, which has been tentatively identified in the commercial PBB mixture, fireMaster BP-6, was at least 50 times more potent as an inducer of AHH activity than the commercial PBB mixture. The induction of AHH by 3,3',4,4'-tetrabromobiphenyl was accompanied by a dose-dependent decrease in both thymus and spleen weights. The thymus and/or spleen weights were decreased in rats treated with the other MC-type PBBs which further supports the correlation between the toxicity of the PBBs and their ability to induce AHH.
本文描述了所有可能的含两个对溴原子的侧向取代多溴联苯(PBB)同系物的合成。使用能够区分苯巴比妥(PB)型和3-甲基胆蒽(MC)型诱导剂的酶学、电泳和配体结合分析方法,对合成的多溴联苯作为未成熟雄性Wistar大鼠肝脏微粒体药物代谢酶诱导剂进行了评估。4,4'-二溴联苯的诱导模式类似于PB,而4,4'-二溴联苯的所有间位溴化衍生物,即3,4,4'-三溴、3,4,4',5-四溴、3,3',4,4'-四溴、3,3',4,4',5-五溴和3,3',4,4',5,5'-六溴联苯,其诱导模式类似于MC。3,4,4'-三溴联苯的实验结果表明,与多氯联苯(PCB)不同,单个间位卤素取代足以消除4,4'-二溴联苯的PB型特征,并将其转化为严格的MC型诱导剂。诱导芳烃羟化酶(AHH)活性的多溴联苯必须在两个对位以及一个、两个、三个或四个间位上有取代。仅含侧向溴原子的多溴联苯的邻位取代也可能得到芳烃羟化酶(AHH)诱导剂化合物。在商业多溴联苯混合物FireMaster BP-6中初步鉴定出的一种MC型多溴联苯,即3,3',4,4'-四溴联苯,作为AHH活性诱导剂的效力至少比商业多溴联苯混合物高50倍。3,3',4,4'-四溴联苯诱导AHH活性的同时,胸腺和脾脏重量出现剂量依赖性下降。用其他MC型多溴联苯处理的大鼠胸腺和/或脾脏重量也下降,这进一步支持了多溴联苯的毒性与其诱导AHH能力之间的相关性。